Statutory Instruments
2016 No. 945
Prisons, England And Wales
Young Offender Institutions, England And Wales
The Prison and Young Offender Institution (Amendment) (No. 2) Rules 2016
Made
21st September 2016
Laid before Parliament
22nd September 2016
Coming into force
17th October 2016
The Secretary of State makes the following Rules in exercise of the powers conferred by sections 47(1) and (3A) of the Prison Act 1952( 1 ).
Citation and commencement
1. These Rules may be cited as the Prison and Young Offender Institution (Amendment) (No. 2) Rules 2016 and come into force on 17th October 2016.
Amendment of the Prison Rules 1999
2. —(1) Rule 2(1) (interpretation) of the Prison Rules 1999( 2 ) is amended as follows.
(2) In the definition of “specified drug”—
(a) after “containing” insert “one or more of the following”;
(b) at the end of sub-paragraph (h) omit “and”, and
(c) after sub-paragraph (i) insert—
“ (j) PB-22 (Quinolin-8-yl-1-pentyl-1H-indole-3-carboxylate);
(k) 5F-MDMB-PINACA (Methyl-[2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate]);
(l) AB-CHMINACA (N-[-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);
(m) 5F-AMB (Methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}amino)-3-methylbutanoate);
(n) AMB-FUBINACA (Methyl-2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)-3-methylbutanoate);
(o) Etizolam (4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine);
(p) ADB-CHMINACA (N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide); ” .
Amendment of the Young Offender Institution Rules 2000
3. —(1) Rule 2(1) (interpretation) of the Young Offender Institution Rules 2000( 3 ) is amended as follows.
(2) In the definition of “specified drug”—
(a) after “containing” insert “one or more of the following”;
(b) at the end of sub-paragraph (h) omit “and”, and
(c) after sub-paragraph (i) insert—
“ (j) PB-22 (Quinolin-8-yl-1-pentyl-1H-indole-3-carboxylate);
(k) 5F-MDMB-PINACA (Methyl-[2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate]);
(l) AB-CHMINACA (N-[-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);
(m) 5F-AMB (Methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}amino)-3-methylbutanoate);
(n) AMB-FUBINACA (Methyl-2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)-3-methylbutanoate);
(o) Etizolam (4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine);
(p) ADB-CHMINACA (N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide); ” .
Sam Gyimah
Parliamentary Under Secretary of State
Ministry of Justice
21st September 2016
1952 c. 52 . Section 47(1) was amended by section 6(2) of the Criminal Justice and Public Order Act 1994 (c. 33) and paragraph 3(2) of Schedule 9 to the Criminal Justice and Courts Act 2015 (c. 2) . Section 47(3A) of the Prison Act 1952 was inserted by section 16(3) of the Criminal Justice and Courts Act 2015.
S.I. 1999/728 ; amended by S.I. 2000/2641 , 2003/3301 , 2005/869 , 2005/3437 , 2008/597 , 2009/3082 , 2013/235 , 2014/2169 , 2016/583 .
S.I. 2000/3371 ; amended by S.I. 2005/897 , 2005/3438 , 2008/599 , 2009/3082 , 2013/235 , 2014/2169 , 2016/583 .